Grandfield & Dodd’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-3,965
Closed -$261K 187
2017
Q1
$261K Hold
3,965
0.03% 165
2016
Q4
$273K Hold
3,965
0.04% 163
2016
Q3
$280K Buy
3,965
+95
+2% +$7.1K 0.04% 159
2016
Q2
$293K Hold
3,870
0.04% 150
2016
Q1
$266K Sell
3,870
-284
-7% -$20.4K 0.04% 150
2015
Q4
$363K Hold
4,154
0.06% 129
2015
Q3
$336K Hold
4,154
0.06% 131
2015
Q2
$369K Buy
4,154
+14
+0.3% +$1.22K 0.06% 131
2015
Q1
$359K Buy
4,140
+200
+5% +$16.8K 0.05% 127
2014
Q4
$334K Sell
3,940
-89
-2% -$6.95K 0.05% 133
2014
Q3
$285K Buy
4,029
+89
+2% +$6.34K 0.04% 138
2014
Q2
$273K Hold
3,940
0.04% 155
2014
Q1
$296K Hold
3,940
0.05% 150
2013
Q4
$277K Hold
3,940
0.05% 150
2013
Q3
$243K Buy
3,940
+120
+3% +$7.76K 0.04% 148
2013
Q2
$236K Buy
+3,820
New +$230K 0.04% 153

Other funds holding ESRX

Grandfield & Dodd's ESRX Position: Q2 2017 in Review

Grandfield & Dodd sold out of Express Scripts Holding Company (ESRX) in Q2 2017, closing a stake of 3,965 shares — an estimated $261K sold.

Grandfield & Dodd first reported a position in ESRX in Q2 2013 and held it in 16 quarters. The position peaked at $369K in Q2 2015. 1,046 funds tracked by Wall St. Rank hold ESRX as of Q2 2017.

  • Grandfield & Dodd reported no remaining Express Scripts Holding Company position as of Q2 2017 after selling out during the quarter.
  • Grandfield & Dodd sold 3,965 Express Scripts Holding Company shares in Q2 2017, an estimated $261K.
  • Grandfield & Dodd first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 16 quarters.
  • Grandfield & Dodd's Express Scripts Holding Company position peaked at $369K in Q2 2015.
  • 1,046 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q2 2017.

Based on Grandfield & Dodd's 13F filing for Q2 2017, filed 27 Jul 2017.